Half of cancer cases occur in patients aged 70 and above. Majority of older patients are eligible for chemotherapy but evidence for treating this population is sparse and severe toxicities affect more than half of them. | Low lean mass and chemotherapy toxicity risk in the elderly The Fraction study protocol